About this trial
This study will be a prospective observation study of the use of PoRSHA for repair in patients with challenging paraesophageal hernias.
One of the most challenging problems facing foregut surgeons is the large and complex paraesophageal hernia (PEH) repair in the older patient. The investigator has demonstrated good outcomes and durability with the initial use of a novel permanent autologous vascularized biologic fascial flap to reconstruct the diaphragmatic hiatus following standard hiatal hernia repair in selected patients. This technique is called a posterior rectus sheath flap hiatal augmentation or PoRSHA, which is performed to enhance the hiatal repair for large (type III and IV) and recurrent PEH. The investigator believes by using the patient's autologous vascularized and peritonealized fascia at the hiatal defect, PoRSHA could increase the strength and restore the hiatal complex properties in ways that synthetic mesh, or a primary repair cannot.
The hypothesis is that PoRSHA is a unique technique that has the potential to supplant current approaches to primary hiatal closure in select cases. By augmenting the hiatal closure with a vascularized fascial sheath, PoRSHA provides the tensile strength needed for the attenuated defects in large and complex PEHs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients undergoing PoRSHA. PoRSHA will be offered to all patients with PEH defects measuring greater than 4 cm.
Disqualifiers
Patients that did not have PoRSHA.
Patients requiring therapeutic anticoagulation perioperatively or those with bleeding disorders, considering the added risk of bleeding at the donor site with exposed rectus muscle.
Trial population
All patients who underwent PoRSHA at UCMC. We estimate 80-100 patients per year. This study is for all racial and ethnic origins.
Trial design
Cohort
Prospective
Treatments tested in this trial
POSTERIOR RECTUS SHEATH HIATAL AUGMENTATION (PORSHA)
Procedure/SurgeryUse of a novel permanent autologous vascularized biologic fascial flap to reconstruct the diaphragmatic hiatus following standard hiatal hernia repair in selected patients. This technique is called a posterior rectus sheath flap hiatal augmentation or PoRSHA.
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with recurrence of hernia as seen radiographically at routine esophagram
Secondary outcomes
Number or participants with Symptom Relief
Number of participants with use of anti-acid medications
Number of participants with dysphagia symptoms
Number of participants with abdominal wall deformities or symptoms
Sponsors and contacts
Click on the lead sponsor to view all of their trials.